Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 279, Issue 6 48-6, 2000, Pages

  Schwöbel, Jörg ^a   Fischer, Tina ^a   Lanz, Bettina ^b   Mohaupt, Markus ^b,c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiotensin II type 1 and type 2 receptor; Dexamethasone; Glomerular inflammation; Inducible nitric oxide synthase

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; NITRIC OXIDE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

EID: 0034543079     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.279.6.f1092     Document Type: Article

References (54)

1. Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells
2. 1 receptors: Expression, signaling, and regulation
3. Importance of nitric oxide in the control of renal hemodynamics
4. Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages
5. Glomerular NO synthase activity in mesangial cell immune injury
6. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells
7. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells
8. Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells
9. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages
10. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages
11. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: Involvement of a nuclear factor kappa B-dependent mechanism
12. Dexamethasene suppresses iNOS gene expression by upregulating I-κB α and inhibiting NF-κB
13. Angiotensin II receptor subtypes in cultured rat mesangial cells
14. Effect of reduction of nitric oxide on plasma and kidney tissue angiotensin II levels
15. Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells
16. Inhibition of pressure natriuresis in mice lacking the AT2 receptor
17. Identification of a cis-acting glucocorticoid responsive element in the rat angietensin II type 1A promoter
18. Renal proximal tubular AT2 receptor: Signaling and transport
19. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophic and hyperplastic agonists
20. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells
21. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes
22. Alpha-adrenergic stimulation enhances inducible nitric oxide synthase expression in rat cardiac myocytes
23. Molecular biology and signaling of angiotensin receptors: An overview
24. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases
25. Nitric oxide in the juxtaglomerular apparatus
26. L-Arginine metabolism in immune-mediated glomerulonephritis in the rat
27. Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells
28. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin
29. Angiotensin II-induced decrease in expression of inducible nitric oxide synthase in rat astroglial cultures: Role of protein kinase C
30. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis
31. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats
32. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis
33. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture
34. Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells
35. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney
36. Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis
37. Noble: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis
38. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction
39. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells
40. The angiotensin (Ang) fragments 1-7 and 3-8 inhibit inducible nitric oxide (NO) synthesis: Comparison with Ang II
41. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis
42. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis
43. The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells
44. 2+ activity and contraction of rat mesangial cells
45. Nitric oxide, sepsis, and the kidney
46. Glucocorticoid and mineralocorticoid regulation of angiotensin II type 1 receptor binding and inositol triphosphate formation in WB cells
47. Cytokines and mesangial cells
48. Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts
49. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered N(G)-monomethyl-L-arginine
50. Angiotensin II is involved in the progression of renal disease: Importance of non-hemodynamic mechanisms
51. AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis
52. Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a posttranscriptional mechanism
53. Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes
54. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis